Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in Carpal Tunnel Syndrome
NCT06282640Phase 4
Key facts
- Status
- Completed
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Countries
- 1
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Drugs
- vitamin d
- Conditions
- carpal tunnel syndrome (CTS)Vitamin D deficiency (VDD)
01
Overview
Phase 4, open-label, single-arm trial of vitamin d in carpal tunnel syndrome (CTS) and Vitamin D deficiency (VDD). Primary endpoint: Electrophysiological scale. Started Dec 2021; status: completed.
02
Design
1 arm- Study design
- Non-randomizedOpen-label
Vitamin D in Carpal Tunnel Syndrome
Patients receive Vitamin D replacement therapy.
03
Who it enrols
Patients with mild to moderate CTS and Vitamin D deficiency (<20 ng/ml). Excludes severe CTS, thenar atrophy, diabetes, RA, thyroid disorders, traumatic nerve injury, polyneuropathy, and recent injections.
04
Endpoints
Primary
Electrophysiological scale
Secondary
Monofilament test
Beyond the preview
Go deeper on NCT06282640.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282640.